Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 2.79 Billion CNY | 13.15% |
| 2022 | 2.47 Billion CNY | 1.66% |
| 2021 | 2.43 Billion CNY | 45.49% |
| 2020 | 1.67 Billion CNY | 21.62% |
| 2019 | 1.37 Billion CNY | 20.25% |
| 2018 | 1.14 Billion CNY | 41.62% |
| 2017 | 807.01 Million CNY | 50.53% |
| 2016 | 536.13 Million CNY | 14.88% |
| 2015 | 466.67 Million CNY | 6.35% |
| 2014 | 438.82 Million CNY | 2.11% |
| 2013 | 429.76 Million CNY | 23.31% |
| 2012 | 348.52 Million CNY | 36.75% |
| 2011 | 254.86 Million CNY | 31.29% |
| 2010 | 194.13 Million CNY | 49.72% |
| 2009 | 129.66 Million CNY | -7.96% |
| 2008 | 140.86 Million CNY | 47.99% |
| 2007 | 95.18 Million CNY | 16.21% |
| 2006 | 81.9 Million CNY | -5.2% |
| 2005 | 86.39 Million CNY | 106.82% |
| 2004 | 41.77 Million CNY | -30.93% |
| 2003 | 60.47 Million CNY | 2.87% |
| 2002 | 58.78 Million CNY | 12.7% |
| 2001 | 52.16 Million CNY | 4.21% |
| 2000 | 50.05 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 965.14 Million CNY | 29.2% |
| 2024 Q2 | 747.03 Million CNY | -23.34% |
| 2024 Q1 | 974.5 Million CNY | 148.15% |
| 2023 Q2 | 771.15 Million CNY | 0.19% |
| 2023 Q3 | 863.81 Million CNY | 12.02% |
| 2023 FY | 2.79 Billion CNY | 13.15% |
| 2023 Q1 | 769.68 Million CNY | 83.32% |
| 2023 Q4 | 392.7 Million CNY | -54.54% |
| 2022 FY | 2.47 Billion CNY | 1.66% |
| 2022 Q4 | 419.85 Million CNY | -43.12% |
| 2022 Q1 | 689.28 Million CNY | 64.12% |
| 2022 Q2 | 625.07 Million CNY | -9.32% |
| 2022 Q3 | 738.12 Million CNY | 18.09% |
| 2021 FY | 2.43 Billion CNY | 45.49% |
| 2021 Q1 | 565.3 Million CNY | 65.02% |
| 2021 Q4 | 419.99 Million CNY | -53.14% |
| 2021 Q3 | 896.22 Million CNY | 62.97% |
| 2021 Q2 | 549.93 Million CNY | -2.72% |
| 2020 Q2 | 396.94 Million CNY | -15.15% |
| 2020 Q3 | 464.18 Million CNY | 16.94% |
| 2020 Q4 | 342.57 Million CNY | -26.2% |
| 2020 FY | 1.67 Billion CNY | 21.62% |
| 2020 Q1 | 467.81 Million CNY | 76.32% |
| 2019 Q4 | 265.32 Million CNY | -26.81% |
| 2019 Q3 | 362.5 Million CNY | 5.94% |
| 2019 FY | 1.37 Billion CNY | 20.25% |
| 2019 Q1 | 404.36 Million CNY | 81.34% |
| 2019 Q2 | 342.17 Million CNY | -15.38% |
| 2018 FY | 1.14 Billion CNY | 41.62% |
| 2018 Q1 | 326.11 Million CNY | 146.48% |
| 2018 Q3 | 302.41 Million CNY | 3.77% |
| 2018 Q4 | 222.98 Million CNY | -26.26% |
| 2018 Q2 | 291.41 Million CNY | -10.64% |
| 2017 Q1 | 226.36 Million CNY | 311.02% |
| 2017 Q4 | 132.31 Million CNY | -45.21% |
| 2017 Q2 | 206.83 Million CNY | -8.63% |
| 2017 FY | 807.01 Million CNY | 50.53% |
| 2017 Q3 | 241.5 Million CNY | 16.77% |
| 2016 Q1 | 146.64 Million CNY | 56.81% |
| 2016 Q4 | 55.07 Million CNY | -68.64% |
| 2016 Q3 | 175.62 Million CNY | 10.6% |
| 2016 Q2 | 158.79 Million CNY | 8.29% |
| 2016 FY | 536.13 Million CNY | 14.88% |
| 2015 Q2 | 136.19 Million CNY | 17.33% |
| 2015 FY | 466.67 Million CNY | 6.35% |
| 2015 Q4 | 93.51 Million CNY | -22.64% |
| 2015 Q3 | 120.88 Million CNY | -11.24% |
| 2015 Q1 | 116.07 Million CNY | -17.12% |
| 2014 Q4 | 140.05 Million CNY | 72.0% |
| 2014 FY | 438.82 Million CNY | 2.11% |
| 2014 Q1 | 115.2 Million CNY | 54.25% |
| 2014 Q3 | 81.42 Million CNY | -20.28% |
| 2014 Q2 | 102.13 Million CNY | -11.35% |
| 2013 Q1 | 106.63 Million CNY | 57.03% |
| 2013 Q2 | 118.38 Million CNY | 11.03% |
| 2013 Q3 | 130.06 Million CNY | 9.86% |
| 2013 Q4 | 74.68 Million CNY | -42.58% |
| 2013 FY | 429.76 Million CNY | 23.31% |
| 2012 Q4 | 67.9 Million CNY | -38.11% |
| 2012 Q3 | 109.71 Million CNY | 34.78% |
| 2012 Q2 | 81.4 Million CNY | -9.05% |
| 2012 Q1 | 89.5 Million CNY | 45.54% |
| 2012 FY | 348.52 Million CNY | 36.75% |
| 2011 Q4 | 61.5 Million CNY | -17.91% |
| 2011 FY | 254.86 Million CNY | 31.29% |
| 2011 Q3 | 74.91 Million CNY | 41.39% |
| 2011 Q2 | 52.98 Million CNY | -19.07% |
| 2011 Q1 | 65.46 Million CNY | 34.23% |
| 2010 FY | 194.13 Million CNY | 49.72% |
| 2010 Q3 | 50.16 Million CNY | -18.52% |
| 2010 Q2 | 61.57 Million CNY | 83.12% |
| 2010 Q4 | 48.77 Million CNY | -2.78% |
| 2010 Q1 | 33.62 Million CNY | 10.95% |
| 2009 Q4 | 30.3 Million CNY | -10.48% |
| 2009 Q2 | 39.52 Million CNY | 52.16% |
| 2009 Q1 | 25.97 Million CNY | -45.56% |
| 2009 Q3 | 33.85 Million CNY | -14.35% |
| 2009 FY | 129.66 Million CNY | -7.96% |
| 2008 Q3 | 23.99 Million CNY | -39.21% |
| 2008 Q4 | 47.71 Million CNY | 98.89% |
| 2008 FY | 140.86 Million CNY | 47.99% |
| 2008 Q1 | 29.69 Million CNY | 45.66% |
| 2008 Q2 | 39.46 Million CNY | 32.91% |
| 2007 Q4 | 20.38 Million CNY | -3.43% |
| 2007 Q3 | 21.11 Million CNY | -17.02% |
| 2007 Q2 | 25.44 Million CNY | -9.94% |
| 2007 Q1 | 28.24 Million CNY | 72.41% |
| 2007 FY | 95.18 Million CNY | 16.21% |
| 2006 Q3 | 27.88 Million CNY | 32.17% |
| 2006 Q4 | 16.38 Million CNY | -41.23% |
| 2006 Q2 | 21.09 Million CNY | 3.42% |
| 2006 FY | 81.9 Million CNY | -5.2% |
| 2006 Q1 | 20.39 Million CNY | -1.4% |
| 2005 FY | 86.39 Million CNY | 106.82% |
| 2005 Q4 | 20.68 Million CNY | -26.69% |
| 2005 Q3 | 28.21 Million CNY | 42.88% |
| 2005 Q2 | 19.74 Million CNY | 11.29% |
| 2005 Q1 | 17.74 Million CNY | 280.89% |
| 2004 Q4 | -9.81 Million CNY | -167.8% |
| 2004 Q2 | 25.7 Million CNY | 125.23% |
| 2004 FY | 41.77 Million CNY | -30.93% |
| 2004 Q1 | 11.41 Million CNY | -37.83% |
| 2004 Q3 | 14.46 Million CNY | -43.7% |
| 2003 Q3 | 14.64 Million CNY | 4.53% |
| 2003 Q2 | 14.01 Million CNY | 4.08% |
| 2003 Q4 | 18.35 Million CNY | 25.32% |
| 2003 FY | 60.47 Million CNY | 2.87% |
| 2003 Q1 | 13.46 Million CNY | -17.63% |
| 2002 FY | 58.78 Million CNY | 12.7% |
| 2002 Q4 | 16.34 Million CNY | 7.77% |
| 2002 Q3 | 15.16 Million CNY | 0.0% |
| 2001 FY | 52.16 Million CNY | 4.21% |
| 2000 FY | 50.05 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.3 Billion CNY | 34.982% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 591.57 Million CNY | -372.867% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 57 Million CNY | -4807.576% |
| Aurora Optoelectronics Co.,Ltd. | -675.27 Million CNY | 514.252% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -38.27 Million CNY | 7408.532% |
| NanJing Pharmaceutical Company Limited | 577.82 Million CNY | -384.117% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 90.07 Million CNY | -3005.457% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.16 Billion CNY | -139.533% |